Truist Securities Starts Altimmune (ALT) at Buy
(Updated - March 18, 2026 3:53 PM EDT)
Truist Securities analyst Srikripa Devarakonda initiates coverage on Altimmune (NASDAQ: ALT) ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Truist Securities analyst Srikripa Devarakonda initiates coverage on Altimmune (NASDAQ: ALT) ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
